Trials / Completed
CompletedNCT03350165
A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 118 (actual)
- Sponsor
- Kowa Company, Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | K-877 | 0.2mg tablet |
| DRUG | Placebo | K-877 matching placebo tablet |
Timeline
- Start date
- 2017-12-27
- Primary completion
- 2019-04-03
- Completion
- 2020-06-30
- First posted
- 2017-11-22
- Last updated
- 2021-04-09
Locations
16 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT03350165. Inclusion in this directory is not an endorsement.